ProBioGen AG is a fully integrated CDMO headquartered in Berlin, Germany, specializing in the development and GMP manufacturing of biopharmaceuticals, viral vectors, and vaccines. The company offers cell line development, process development, GMP manufacturing up to 1000L bioreactors, and comprehensive analytical services. ProBioGen leverages proprietary technologies including GlymaxX (ADCC enhancement), DirectedLuck (transposase system), and CHO.RiGHT production systems.
biologics CDMO, viral vector manufacturing (AAV, lentivirus, poxvirus), cell line development, GMP biomanufacturing, proprietary glycoengineering technologies
1 site worldwide
No reviews available yet.
No documents available.